What Can Proteomics Tell us About COVID-19 Infections? Mass Spectrometry as a Tool to Find New Proteins as Biomarkers
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Proteomic studies using mass spectrometry are crucial for identifying COVID-19 biomarkers in blood. This review explores methods and challenges in discovering these vital proteins for disease understanding and prognosis.
Area Of Science
- Biochemistry
- Immunology
- Proteomics
Background
- The COVID-19 pandemic necessitates the identification of reliable blood biomarkers for disease prognosis and understanding.
- Proteomic analysis, particularly mass spectrometry (MS), is vital for discovering proteins associated with SARS-CoV-2 infection.
- Plasma and serum contain potential biomarkers, but high-abundance proteins like albumin can obscure low-abundance, critical markers.
Purpose Of The Study
- To review proteomic approaches for discovering novel plasma biomarkers of COVID-19.
- To discuss the challenges associated with analyzing blood samples for biomarker discovery.
- To highlight the role of MS in identifying proteins indicative of infection, severity, and immune response.
Main Methods
- Review of recently published studies employing proteomic techniques for COVID-19 biomarker discovery.
- Discussion of mass spectrometry (MS) based proteomics for protein identification and quantification in patient samples.
- Exploration of sample preparation strategies, including depletion and fractionation, to enhance the detection of low-abundance proteins.
Main Results
- MS-based proteomics has successfully identified biomarkers linked to COVID-19 infection, disease severity, and immune responses.
- Various proteomic strategies are being employed to uncover new diagnostic and prognostic indicators.
- Challenges in sample preparation and data analysis impact the reliability and identification of biomarkers.
Conclusions
- Proteomic analysis of blood offers significant potential for understanding COVID-19 pathogenesis and outcomes.
- Effective biomarker discovery requires overcoming challenges in sample processing and data interpretation.
- Continued research into advanced proteomic techniques is essential for developing effective COVID-19 diagnostics and therapeutics.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...